Board of Directors
Jan-Olof brings international business experience on management and CEO level, mainly from the chemical and biotech industries VBB AB, EKA Chemicals AB, Berol Verkstadskemi AB (part of the Akzo Nobel group) and, most recently, from Diffchamb AB (publ.).
Chief Executive Officer
Emma joined Isogenica as Chief Executive Officer in September 2018. She is passionate about technologies that can accelerate drug discovery and development, and experienced in leading highly innovative, scientific companies from start-up through multiple product launches, to rapidly growing sustainable businesses.
Renny is currently interim CEO of the Eastern Academic Health Sciences Network (AHSN) based at Addenbrooke’s Hospital in Cambridge. Prior to that he founded the South West AHSN across Devon Somerset and Cornwall working in partnership with the academic